Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022003541 - TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

Publication Number WO/2022/003541
Publication Date 06.01.2022
International Application No. PCT/IB2021/055772
International Filing Date 28.06.2021
IPC
A61K 31/05 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61P 25/22 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
CPC
A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 9/0014
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0014Skin, i.e. galenical aspects of topical compositions
A61K 9/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
06Ointments; Bases therefor; ; Other semi-solid forms, e.g. creams, sticks, gels
A61P 25/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
A61P 25/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
Applicants
  • ZYNERBA PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • GRIESSER, John
  • DOBBINS, Thomas W.
  • SEBREE, Terri
Agents
  • HANRAHAN, Benedict L.
  • HERRITT, Danielle L.
Priority Data
63/045,66429.06.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
(FR) TRAITEMENT DU SYNDROME DE L'X FRAGILE AU MOYEN DE CANNABIDIOL
Abstract
(EN) The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.
(FR) La présente technologie concerne une méthode de traitement d'un ou de plusieurs symptômes du syndrome de l'X fragile à méthylation complète (Fmet) chez un sujet qui consiste à administrer une quantité efficace de cannabidiol au sujet de façon à traiter un ou plusieurs symptômes du syndrome de l'X fragile.
Latest bibliographic data on file with the International Bureau